Additionally, lipid profiles (triglyceride, total cholesterol, HDL-C, LDL-C, small dense LDL-C), AST, and ALT in patients with MASLD or NAFLD were worse than those in patients without MASLD or NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.